CNE100005XY6
CNE100005XY6
CHANGCHUN BCHT BIOTECHNOLOGY CO
Loading chart...
Company Profile
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. It offers therapeutic biological products; general cargo road transport; special cargo transport and import and export of goods and technology. The company's products Varicella vaccine, nasal spray flu vaccine, herpes zoster vaccine, liquid nasal spray flu vaccine. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China.
Related stocks
Key Metrics & Overview
Detailed metrics & financial data of the company
Company Profile
5
MetricsCountry
Region
Sector
Website
🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
7/7 Very High
5Y Volatility
44.2% p.a.
Max Drawdown (5Y)
-85.6%
Sharpe Ratio (5Y)
-0.70
Beta Factor
0.09
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (44.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -85.6% in the extended horizon.